Immunic (IMUX) Capital Expenditures (2013 - 2026)
Immunic (IMUX) posted Capital Expenditures of $249,000 for Q2 2026, up 591.7% from $36,000 a year earlier.
Powered by 
Analysis
Immunic (IMUX) Capital Expenditures (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Immunic was $329,000, up 141.9% year-over-year; for FY2025, it came in at $161,000, down 39.0% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 2.0% (FY2020 to FY2025).
- In prior years, Immunic's Capital Expenditures was $264,000 in FY2024 (-21.0%), $334,000 in FY2023 (+198.2%), $112,000 in FY2022 (+67.2%) and $67,000 in FY2021 (-54.1%).
- The Q2 2026 figure stands as the highest quarterly Capital Expenditures since Q1 2017.
- On a year-over-year basis, Capital Expenditures increased in five of the last eight quarters, with growth averaging 85.5%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2023, with growth of 766.7%; the weakest was Q4 2024, with a decline of 98.2%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $2,000 (Q1 2026), $11,000 (Q4 2025) and $67,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Immunic | 319.70 Mn | -72.64 Mn | - | 249,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 249,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 180,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Sep 30, 2023 | 44,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Sep 30, 2021 | 20,000.00 |
API Access
Immunic Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMUX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "IMUX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMUX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();